Not so accidental outcomes following cerebrovascular accidents James F. Meschia Invited Commentary 01 October 2004 Pages: 341 - 342
Memantine approved to treat moderate to severe Alzheimer’s disease Karen Marder Clinical Trials Report 01 October 2004 Pages: 349 - 350
Genetics and genetic counseling: Recommendations for Alzheimer’s disease, frontotemporal dementia, and Creutzfeldt-Jakob disease Jennifer WilliamsonSusan LaRusse OriginalPaper 01 October 2004 Pages: 351 - 357
Diagnosis, risk factors, and treatment of vascular dementia Oscar L. LopezLewis H. KullerJames T. Becker OriginalPaper 01 October 2004 Pages: 358 - 367
Estrogen replacement therapy, Alzheimer’s disease, and mild cognitive impairment Ruth A. MulnardMar`ia M. CorradaClaudia H. Kawas OriginalPaper 01 October 2004 Pages: 368 - 373
Cognitive reserve: Implications for diagnosis and prevention of Alzheimer’s disease Nikolaos ScarmeasYaakov Stern OriginalPaper 01 October 2004 Pages: 374 - 380
Neuro-ophthalmology of von Hippel-Lindau Eric W. FitzSteven A. Newman OriginalPaper 01 October 2004 Pages: 384 - 390
Retinal, ophthalmic, or ocular migraine Shilpi PradhanSophia M. Chung OriginalPaper 01 October 2004 Pages: 391 - 397
Medical and surgical management of idiopathic intracranial hypertension in pregnancy Rosa A. TangE. Ulysses DorotheoHasan M. Bahrani OriginalPaper 01 October 2004 Pages: 398 - 409
Experience of the optic neuritis treatment trial James Corbett Clinical Trials Report 01 October 2004 Pages: 412 - 412
Autosomal recessive forms of Charcot-Marie-Tooth disease J. M. VallatD. GridM. Tazir OriginalPaper 01 October 2004 Pages: 413 - 419
New advances in identifying genetic anomalies in stroke-prone probands James F. MeschiaBradford B. Worrall OriginalPaper 01 October 2004 Pages: 420 - 426